A clinical trial is a research study that is designed to improve health and cancer care. They are a crucial part in the fight against cancer because they allow researchers to test out new and innovative treatment options.
Many women with ovarian cancer do choose to participate in clinical trials, and as a result, may be able to take part in a treatment option that is potentially life-saving, but has not yet been granted federal approval.
In addition to being granted access to new treatments, clinical trials are really important to the scientific community overall. Recent ovarian cancer trials have even suggested that ovarian cancer in its advanced stages could be curable. Recent trials have looked at using immunotherapy in combination with other treatments to treat ovarian cancer that has returned — and shown really promising results.
Any research that can help women live longer and better lives after ovarian cancer recurs — which unfortunately, happens really often — is incredibly important for the field. While 80% of women who are diagnosed with ovarian cancer will go into remission, 70-80% of those women will experience a recurrence.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Cassandra Niemi is a gynecologic oncologist at Compass Oncology. Read More
A clinical trial is a research study that is designed to improve health and cancer care. They are a crucial part in the fight against cancer because they allow researchers to test out new and innovative treatment options.
Many women with ovarian cancer do choose to participate in clinical trials, and as a result, may be able to take part in a treatment option that is potentially life-saving, but has not yet been granted federal approval.
Read More
In addition to being granted access to new treatments, clinical trials are really important to the scientific community overall. Recent ovarian cancer trials have even suggested that ovarian cancer in its advanced stages
could be curable. Recent trials have looked at using immunotherapy in combination with other treatments to treat ovarian cancer that has returned — and shown really promising results.
Any research that can help women live longer and better lives after ovarian cancer recurs — which unfortunately, happens really often — is incredibly important for the field. While 80% of women who are diagnosed with ovarian cancer will go into remission, 70-80% of those women will experience a recurrence.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Cassandra Niemi is a gynecologic oncologist at Compass Oncology. Read More
